How Do Beta Blockers Affect VO2 Max?

Beta blockers lower your VO2 max, typically by somewhere around 5 to 15 percent depending on the drug, the dose, and your physiology. The reduction stems from a capped heart rate that limits how much oxygen your cardiovascular system can deliver during all-out effort, but the story is more nuanced than “slower heart equals less oxygen.” Your body compensates in ways that blunt part of the hit, the type of beta blocker matters a great deal, and you can still make meaningful fitness gains while taking one.

Why a Lower Heart Rate Doesn’t Tell the Full Story

The most obvious thing a beta blocker does during exercise is hold your heart rate down. In a large study of people on beta-blocker therapy, maximal heart rate was about 19 percent lower than in those not taking the drug.¹ That sounds like it should slash cardiac output by a similar fraction, since cardiac output equals heart rate multiplied by the volume of blood pumped per beat. But the body fights back. When the heart beats more slowly, each beat has more time to fill, so stroke volume rises to partially offset the slower rate. Research on men and women given beta blockers confirmed that while heart rate and overall cardiac output fell, stroke volume increased significantly.² Older work found that even though clinical doses of beta blockers can cut heart rate by 30 to 35 percent, cardiac output does not drop by nearly that much.³

Beyond the heart itself, oxygen delivery during exercise also depends on how well blood vessels in working muscles dilate and how efficiently the muscles extract oxygen. A substantial body of evidence suggests these peripheral factors play a larger role in controlling how much oxygen you actually use than is often appreciated.⁴ So while a capped heart rate is the headline effect, the actual hit to VO2 max is smaller than you’d predict from the heart rate reduction alone, because stroke volume compensation and peripheral oxygen extraction pick up some of the slack.

Putting Numbers on the Drop

One well-controlled study measured peak VO2 in healthy adults given propranolol, a classic non-selective beta blocker. On placebo their average was about 42 ml/kg/min; after acute propranolol it fell to around 40, and after chronic (ongoing) treatment it settled near 39, a reduction of roughly 5 to 8 percent. Time to exhaustion on an exercise test dropped by about 5 percent under both dosing schedules, and the cumulative work output fell by a similar margin.⁵ That study is notable because it showed the drop in peak VO2 was essentially the same whether you’d been on the drug for days or had just taken a single dose. What did differ between acute and chronic treatment were the hemodynamic and metabolic pathways by which the body arrived at that same reduced ceiling, meaning your physiology adapts its compensatory strategy over time even though the endpoint doesn’t change much.

In people with heart conditions rather than healthy volunteers, the hit can be larger and more functionally meaningful. A study in patients with permanent atrial fibrillation found that both metoprolol and carvedilol significantly lowered peak VO2 compared to baseline, while the calcium channel blockers diltiazem and verapamil preserved it.⁶ And in heart failure patients with preserved ejection fraction who stopped their beta blocker, peak VO2 jumped from about 12.2 to 14.3 ml/kg/min, a gain of roughly 2 ml/kg/min, which is a clinically substantial improvement in a population that often struggles with everyday exertion.⁷ For context, 1 ml/kg/min of VO2 max can be the difference between comfortably climbing a flight of stairs and needing to stop halfway up.

Selective Versus Non-Selective Beta Blockers

Not all beta blockers hit your exercise capacity the same way. The drugs divide broadly into beta-1-selective agents (metoprolol, atenolol, bisoprolol) that mainly target heart receptors, and non-selective agents (propranolol, timolol, carvedilol) that also block beta-2 receptors found in blood vessels and skeletal muscle. This distinction matters for exercise because beta-2 receptors help dilate airways and blood vessels in working muscles. Block those and you lose some of that peripheral compensation.

In a direct comparison, the non-selective beta blocker reduced continuous exercise performance by about 10 percent, while the beta-1-selective agent reduced it by roughly 5 percent.⁸ That’s roughly double the impairment for the non-selective drug. The gap makes intuitive sense: if your body’s main way of coping with a slower heart rate is to widen blood vessels in working muscles, blocking the receptors that drive that widening undercuts the workaround.

Among beta-1-selective drugs, there are further differences. Nebivolol, which has an additional vasodilating property through nitric oxide release, performed notably better in head-to-head testing against atenolol. Unlike atenolol, nebivolol did not decrease maximal or endurance exercise capacity and did not significantly increase how hard the exercise felt.⁹ If you’re someone whose doctor has flexibility in choosing which beta blocker to prescribe and exercise capacity matters to you, this kind of within-class difference is worth a conversation.

How Beta Blockers Change Your Fuel Mix and Perceived Effort

Beyond limiting oxygen delivery, beta blockers shift how your body fuels exercise. Under normal conditions, moderate-intensity exercise draws heavily on fat oxidation. Propranolol suppresses the enzymes involved in breaking down stored fat during exercise, pushing the body to rely more on carbohydrate. One study found that during exercise on propranolol, blood glucose was lower, lactate was higher, and the respiratory exchange ratio was elevated, all consistent with a shift away from fat burning and toward carbohydrate combustion.¹⁰ This matters for longer-duration efforts where your carbohydrate stores are finite. You may bonk sooner if your body can’t tap fat as effectively.

Interestingly, the metabolic picture is less dramatic with beta-1-selective drugs. A study of bisoprolol at the maximal lactate steady state found no significant differences in oxygen consumption, carbon dioxide production, blood lactate, or how hard people rated the effort compared to placebo.¹¹ This reinforces the pattern from the previous section: beta-1-selective agents cause less metabolic disruption than non-selective ones, because blocking beta-2 receptors in muscle and fat tissue is what drives the fuel-mix shift.

Perceived exertion, though, tends to rise regardless of selectivity. At any given workload, people on beta blockers report the effort feels harder than it does without the drug.¹² This is partly because you’re working at a higher percentage of your now-reduced maximum heart rate, and partly because catecholamine signaling that normally buffers the sensation of effort is blunted. If you train using heart-rate zones, the numbers will need to be recalibrated. If you train by feel, expect a recalibration period where familiar paces feel surprisingly hard.

Can You Still Improve Your Fitness?

Yes. Beta blockers lower the ceiling, but they don’t prevent the elevator from going up. Exercise training on beta blockers still improves aerobic capacity, though the size of the improvement depends on the population. In healthy and hypertensive individuals, the gain in VO2 max is attenuated by around 10 percent compared to what would be expected without the drug. In patients with coronary heart disease or recovering from a heart attack, training improvements can be larger, in the range of 30 percent increases in VO2 max.¹³ The bigger relative gains in cardiac patients make sense: they start from a lower baseline and have more room for improvement regardless of the pharmacological constraint.

A study that specifically tracked training adaptations across drug groups found that the magnitude of VO2 max improvement did not differ significantly between people on beta blockers and those on placebo, suggesting the drug doesn’t block the adaptive signaling pathways that drive fitness gains.¹⁴ Your trained VO2 max will still be lower than it would be without the drug, but the trajectory of improvement is preserved. That’s a meaningful distinction: the drug shifts your curve down, not flatter.

From a practical standpoint, the standard advice is to base your training zones on your actual on-drug heart rate rather than predicted values from age-based formulas, since those formulas were derived from unmedicated populations. A stress test while on your medication gives you the most accurate ceiling to work from.

Why Some People Feel the Hit More Than Others

Individual variation in how much beta blockers affect exercise capacity is substantial, and genetics play a role. Polymorphisms in the beta-2 adrenergic receptor gene influence exercise capacity in heart failure patients. Those carrying a less common variant at position 164 had a peak VO2 nearly 3 ml/kg/min lower than those with the more common version, and were eight times more likely to have a severely reduced peak VO2.¹⁵ Variants at position 16 of the same receptor also made a measurable difference. While this research was conducted in heart failure patients rather than healthy exercisers, it illustrates that the receptor your beta blocker is blocking isn’t identical from person to person. Two people on the same drug at the same dose can have meaningfully different exercise responses.

Another overlooked factor is potassium handling. During maximal exercise, potassium floods out of contracting muscles into the blood. This rise in extracellular potassium interferes with muscle contraction and contributes to exhaustion. In subjects on beta blockers, potassium concentrations at the point of exhaustion were virtually identical across non-selective blockade, selective blockade, and placebo, even though work capacity differed.¹⁶ This suggests that potassium-driven muscle fatigue may represent a hard physiological wall that determines the point of failure, and beta blockers may cause you to reach that wall at a lower absolute workload.

Exercising in the Heat

If you exercise outdoors in warm weather, beta blockers add a wrinkle to thermoregulation. Propranolol significantly increased forearm vascular resistance and lowered blood flow to the skin during prolonged exercise in heat. Normally your body cools itself by shunting blood to the skin where heat can dissipate, so reduced skin blood flow seems like a recipe for overheating. But the study found that core temperature didn’t rise significantly more on the drug, apparently because the body compensated through increased sweat production and lower skin temperature.¹⁷ The takeaway isn’t that heat is safe on beta blockers, but that your body works harder to maintain temperature stability, and that effort comes at a cost. You may fatigue sooner, and the margin of safety before heat illness narrows even if core temperature holds steady.

People exercising on beta blockers in hot environments should pay close attention to hydration, since the drug may drive higher sweat rates to compensate for reduced skin blood flow. Scaling back intensity on hot days is a sensible precaution when your thermoregulatory system is running with less slack.

When Calcium Channel Blockers Are an Option

For people who need heart rate control but find beta blockers too limiting for their exercise goals, calcium channel blockers are sometimes an alternative worth discussing with a cardiologist. In the atrial fibrillation study mentioned earlier, diltiazem and verapamil controlled heart rate while preserving peak VO2, whereas metoprolol and carvedilol reduced it significantly.⁶ Calcium channel blockers slow the heart through a different electrical pathway and don’t suppress the catecholamine response that helps maintain cardiac output and mobilize fuel during exercise. The tradeoff is that beta blockers have stronger evidence for certain conditions, particularly heart failure and post-heart-attack survival, so exercise tolerance alone doesn’t determine the best drug choice. But in conditions where both classes are medically appropriate, the exercise capacity difference is real and worth factoring into the decision.

What Happens When You Stop

For patients whose clinical situation allows discontinuation, the exercise capacity rebound can be surprisingly quick and substantial. In the study of heart failure patients with preserved ejection fraction, stopping the beta blocker raised peak VO2 by about 2 ml/kg/min, and the percentage of predicted peak VO2 jumped from roughly 69 percent to 81 percent.⁷ That’s the kind of gain that translates into noticeably more energy during daily activities and exercise. It also underscores that at least part of the exercise limitation on beta blockers is purely pharmacological rather than structural. The heart and muscles haven’t lost capacity; the drug is holding them back. Once the chemical brake is released, the underlying fitness reasserts itself.

Stopping a beta blocker without medical supervision is dangerous, particularly if you’ve been on one for a long time. Abrupt withdrawal can trigger rebound tachycardia, blood pressure spikes, and in people with coronary disease, angina or even heart attacks. The decision to discontinue should always be medically supervised with a gradual taper. But the data do suggest that if your doctor determines you no longer need the drug, the exercise capacity payoff is real and not something you have to slowly rebuild through training.